Ann: Change of Director's Interest Notice - J Diddams, page-2

Mr Diddams as a director has always been prepared to put his board pay where his mouth is. Recently, he has also done the same at Aroa Biosurgery. Well done ! Now let us see a second salvo form the Chairman and opening salvos from Ms Lindgren (who has been on the board for 2 1/2 years) and Ms Custin.

Please note I have now upgraded my sentiment from Sell to Hold. While I suspect we will still trade down until such time as we have cleared the necessary capital raise, it is hard to argue at @40-42 cents, that the business materially overvalued. If we get a clear plan from Ms Thomas and raise enough cash to get to profitability, I will move my sentiment to buy and probably re-enter the stock. The fly in the ointment would remain the suitability of the Chairman but if I can see the path to profitability, I am probably prepared to overlook that issue.